百濟(jì)神州：百澤安（替雷利珠單抗注射液）新適應(yīng)癥上市許可申請獲得歐洲藥品管理局受理

array(1) { [372119]=> array(2) { [2]=> array(4) { [0]=> string(6) "歐洲" [1]=> string(6) "藥品" [2]=> string(12) "單抗概念" [3]=> string(14) "百濟(jì)神州-U" } [4]=> array(1) { [0]=> string(19) "同花順7x24快訊" } } }